Levi &Korsinsky, LLP notifies investors in Neogen Corporation (“Neogen Corporation” or the “Company”) (NASDAQ: NEOG) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neogen Corporation investors who were adversely affected by alleged securities fraud between January 5, 2023 and June 3, 2025. Follow the link […]

Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capricor investors who were adversely affected by alleged securities fraud between October 9, 2024 and July 10, 2025. Follow the link

Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. (“Biohaven Ltd.” or the “Company”) (NYSE: BHVN) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Biohaven Ltd. investors who were adversely affected by alleged securities fraud between March 24, 2023 and May 14, 2025. Follow the

Levi & Korsinsky, LLP notifies investors in XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (“XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP” or the “Company”) (NYSE: XIFR) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP investors

Levi & Korsinsky, LLP notifies investors in Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Centene investors who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. Follow the link below

Levi &Korsinsky, LLP notifies investors in iRobot Corporation (“iRobot Corporation” or the “Company”) (NASDAQ: IRBT) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRobot Corporation investors who were adversely affected by alleged securities fraud between January 29, 2024 and March 11, 2025. Follow the link

Levi & Korsinsky, LLP notifies investors in Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Petco investors who were adversely affected by alleged securities fraud between January 14, 2021 and June 5, 2025.

Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. (“Hims & Hers Health, Inc.” or the “Company”) (NYSE: HIMS) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Hims & Hers Health, Inc. investors who were adversely affected by alleged securities fraud between

Levi &Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22, 2023 and June 24, 2025. Follow the link below

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market GlobeNewswire August 22, 2025 RA'ANANA, Israel, Aug. 22, 2025 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, has